The vascular endothelial growth factor system-a new player in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease

Henning Grønbæk; Anders Mellemkjær; Søren Nielsen; Faidon Magkos

doi:10.21037/hbsn-23-552

The vascular endothelial growth factor system-a new player in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease

Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):963-965. doi: 10.21037/hbsn-23-552. Epub 2023 Nov 15.

Authors

Henning Grønbæk^{1

2}, Anders Mellemkjær^{1

2}, Søren Nielsen^{2

3}, Faidon Magkos⁴

Affiliations

¹ Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
² Clinical Institute, Aarhus University, Aarhus, Denmark.
³ Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
⁴ Department of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg, Denmark.

No abstract available

Keywords: Vascular endothelial growth factor B (VEGF-B); metabolic dysfunction-associated steatotic liver disease (MASLD); non-alcoholic fatty liver disease (NAFLD).

Publication types

Editorial
Comment